Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “meloxicam”

106 pharma patents match "meloxicam" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 106
Index total 30,257
Page 1 / 5

Quick answer

This filtered view shows 106 pharmaceutical patents matching "meloxicam" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

106 results for “meloxicam” · 30,257 patents in full index Clear search

  1. US 12370196

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jul 29, 2025 · Expires Jul 24, 2045

    granted

  2. US 12357640

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted

  3. US 12128052

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Oct 29, 2024 · Expires Oct 24, 2044

    granted

  4. US 12005118

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted

  5. US 11998552

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted

  6. US 11944683

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted

  7. US 11865117

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted

  8. US 11826354

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  9. US 11826370

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  10. US 11806354

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted

  11. US 11801250

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted

  12. US 2023302008

    METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM IN A BOLUS DOSE

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Sep 28, 2023 · Expires Sep 23, 2043

    granted

  13. US 11759522

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  14. US 11738085

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted

  15. US 11712441

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted

  16. US 11628173

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  17. US 11617791

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  18. US 11617756

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  19. US 11617755

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted

  20. US 11607456

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  21. US 11602563

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  22. US 11571428

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted

  23. US 11510927

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted

  24. US 11504429

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.